Northwest Financial Advisors Astrazeneca PLC Transaction History
Northwest Financial Advisors
- $145 Billion
- Q2 2024
A detailed history of Northwest Financial Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Northwest Financial Advisors holds 1,136 shares of AZN stock, worth $75,282. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,136
Previous 1,136
-0.0%
Holding current value
$75,282
Previous $77 Million
15.11%
% of portfolio
0.06%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,347Shares Held
492MCall Options Held
4.99MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.3 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$2.82 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.69 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.43 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.17 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $205B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...